Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

@article{Stefano2000RifaximinVC,
  title={Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.},
  author={Michele Di Stefano and Simona Malservisi and Graziamaria Veneto and Antonella Ferrieri and Gino R Corazza},
  journal={Alimentary pharmacology & therapeutics},
  year={2000},
  volume={14 5},
  pages={551-6}
}
BACKGROUND Bacterial overgrowth of the small intestine is a condition characterized by nutrient malabsorption due to an excessive number of bacteria in the lumen of the small intestine. Current treatment is based on empirical courses of broad spectrum antibiotics; few controlled data, with respect to the duration and choice of antibiotic drug, exist at present. The recent availability of rifaximin, a non-absorbable rifamycin derivative, highly effective against anaerobic bacteria, prompted us… CONTINUE READING
44 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Similar Papers

Loading similar papers…